IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 19 filers reported holding IBERE PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10 | -99.9% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $10,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2022 | $10,000 | -99.5% | 1,000 | -99.5% | 0.00% | -100.0% |
| Q3 2021 | $2,110,000 | -6.8% | 211,064 | -6.3% | 0.04% | +5.7% |
| Q2 2021 | $2,265,000 | -34.6% | 225,360 | -35.9% | 0.04% | -30.0% |
| Q1 2021 | $3,464,000 | – | 351,348 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |